Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)

2649
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

The company focuses on the following seven platforms in healthcare field: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

It operates through the following segments: Pharmaceuticals, Human Vaccines and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.

The company was founded in 1994 and is headquartered in Paris, France.

Number of employees : 112 128 persons.
Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Pharmaceuticals28,87182.6%27,25082.7% -5.95%
Human Vaccines3,89711.2%3,71611.3% -4.87%
Animal Health2,1796.2%1,9856% -9.77%
Others-----
Sales per Regions
20122013Delta
EUR (in Million)%EUR (in Million)%
Other Countries12,45135.6%11,44134.7% -8.83%
United States10,87331.1%10,43331.7% -4.22%
Europe (Excluding France)8,21023.5%7,93324.1% -3.49%
France2,8468.1%2,5717.8% -10.7%
Canada567.001.6%573.001.7% +1.05%
Managers
NameAgeSinceTitle
Serge Weinberg632009Chairman & Chief Executive Officer
Jérôme Contamine572009Chief Financial Officer & Executive Vice President
Elias E. Zerhouni, MD632011President-Global Research & Development
Bruno Ménard-2011Chief Information Officer
Ji Zhang, PhD-2003Head-Research & Development Scientific Platforms
Gary J. Nabel MD, PhD-2012Chief Scientific Officer & Senior Vice President
Paul Chew, PhD-2013Chief Medical Officer & Senior Vice President
Igor Landau702004Director
Robert Castaigne, PhD682000Independent Director
Jean-René Fourtou752004Independent Director
Shareholders
NameShares%
L'Oréal SA 118,444,357 8.93%
Norges Bank Investment Management 28,497,058 2.15%
Dodge & Cox 21,054,665 1.59%
Amundi SA (Investment Management) 17,728,755 1.34%
Plan d'Epargne Entreprise Sanofi Synthelabo 17,336,548 1.31%
The Vanguard Group, Inc. 16,287,780 1.23%
Natixis Asset Management SA 16,170,709 1.22%
BlackRock Fund Advisors 10,477,562 0.79%
FIL Investments International 10,231,768 0.77%
THEAM SAS 8,798,111 0.66%
Holdings
NameShares%Valuation
Regeneron Pharmaceuticals Inc (REGN) 22,657,68522.7%9,428,089,305 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 9,110,78611.8%916,089,532 USD
Sanofi (SAN) 8,734,4440.66%847,801,557 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%815,253,552 USD
Sanofi India Ltd (SANOFI) 13,909,58760.4%815,253,552 USD
Zentiva SA (ROSCD) 312,341,64974.9%134,403,735 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 2,846,0004.69%44,026,254 USD
Immune Design Corp (IMDZ) 917,4295.44%29,183,416 USD
GlycoMimetics Inc (GLYC) 1,193,6256.32%11,554,290 USD
Proteome Sciences plc (PRM) 54,0000.025%21,564 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
NOVARTIS AG
ROCHE HOLDING LTD..
PFIZER INC.
MERCK & CO., INC.
SANOFI
BAYER AG
ACTAVIS PLC
NOVO NORDISK A/S
GLAXOSMITHKLINE P..
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
VALEANT PHARMACEU..
TEVA PHARMACEUTIC..
SHIRE PLC
REGENERON PHARMAC..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
CSL LIMITED
Sector Pharmaceuticals
Sanofi : Connections
Research!America
Piasa SA
Sasa Industrie SAS
Institute of Medicine
VL Holding (France)
Financière BFSA
Mayo Clinic
Académie Nationale de Médecine
Genzyme Corp.
Sanofi-Aventis Europe SAS
Sanofi Aventis Participations SA
Alliance Automotive Group SAS
Lasker Foundation
King Abdullah University of Science & Technology
Financière Piasa
National Academy of Engineering
Piasa Holding
The Johns Hopkins University
INSEAD
Pharmaceutical Research & Manufacturers of America
Financières SASA
Sanofi-Aventis U.S. LLC
Montres CORUM Sàrl
Sanofi Pasteur Holding SA
Bordeaux University Foundation
Weinberg Capital Partners SAS
Company contact information
54 rue la Boétie
FR-75008 Paris
France

Phone : +33 (0)1 53 77 40 00
Fax : +33 (0)1 53 77 44 63
Internet : http://www.sanofi.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment A
- Euronext 100 / Stoxx Europe 50, CAC 40, CAC All Shares, EuroStoxx 50, FTSE Eurotop 100, CAC Large 60, CAC All-Tradable, Stoxx Global 200, Stoxx France 50
Stock Exchange Codes
- ISIN Code :  FR0000120578
- Bloomberg Code :  SAN:FP
- Reuters Code :  SASY.PA
- Datastream Code :  F:SQ@F
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF